RKDA Share Price Performance
US$4.45
1.86 (71.74%)
62.9% undervalued intrinsic discount
US$12.00
Fair Value
Price US$4.45
AnalystConsensusTarget US$12.00
Fair ValueUS$12.00
Share PriceUS$4.45
62.9% undervalued intrinsic discount
RKDA Community Narratives
AN
Fair Value US$12.00 62.9% undervalued intrinsic discount
Zola Distribution Expansion Will Unlock Enduring Market Strength
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
RKDA Community Fair Values
- US$12.00FV62.9% undervalued intrinsic discount25.66%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative14 days ago author updated this narrative
Recent RKDA News & Updates
No updates
Arcadia Biosciences, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.56
- Gross Margin
- 41.69%
- Net Profit Margin
- -14.66%
- Debt/Equity Ratio
- 0%
Arcadia Biosciences, Inc. Competitors
About RKDA
- Founded
- 2002
- Employees
- 9
- CEO
- WebsiteView website
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 12.3%
- 1 Year: 21.3%
- Year to Date: 7.0%
In the last week, the market has fallen 1.2%, dragged down most by the Consumer Discretionary. As for the longer term, the market has actually risen by 21% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading